Clinivantage Healthcare Technologies Profile
Key Indicators
- Authorised Capital ₹ 4.10 M
as on 15-12-2024
- Paid Up Capital ₹ 4.10 M
as on 15-12-2024
- Company Age 8 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 79.43%
(FY 2019)
- Profit -771.04%
(FY 2019)
- Ebitda -2283.01%
(FY 2019)
- Net Worth -697.80%
(FY 2019)
- Total Assets 254.26%
(FY 2019)
About Clinivantage Healthcare Technologies
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.10 M and a paid-up capital of Rs 4.10 M, as per Ministry of Corporate Affairs (MCA) records.
Abhay Chopada, Nilesh Jain, and Priti Jain serve as directors at the Company.
- CIN/LLPIN
U72900MH2016PTC286235
- Company No.
286235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Sep 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Clinivantage Healthcare Technologies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nilesh Jain  | Director | 26-Sep-2016 | Current |
Abhay Chopada  | Director | 26-Sep-2016 | Current |
| Priti Jain | Director | 03-Dec-2022 | Current |
Financial Performance of Clinivantage Healthcare Technologies.
Clinivantage Healthcare Technologies Private Limited, for the financial year ended 2019, experienced significant growth in revenue, with a 79.43% increase. The company also saw a substantial fall in profitability, with a 771.04% decrease in profit. The company's net worth observed a substantial decline by a decrease of 697.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clinivantage Healthcare Technologies?
In 2021, Clinivantage Healthcare Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ipkinect Innovations Private LimitedActive 4 years 11 months
Abhay Chopada and Nilesh Jain are mutual person
- Clinivantage Healthcare Pharma Private LimitedActive 5 years 4 months
Nilesh Jain is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Clinivantage Healthcare Technologies?
Clinivantage Healthcare Technologies has a workforce of 25 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clinivantage Healthcare Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinivantage Healthcare Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
